EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Strain-specific pathogenicity and antibody-dependent enhancement of dengue virus infection in Ifnar1–Ifngr1 double-knockout mice

Takayuki Hishiki, Milagros Virhuez-Mendoza, Yusuke Sakai, Akihiko Uda, Seiya Ozono, Yuko Sato, Sorane Machiya, Kotomi Sato, Yuta Utsui, Shigeru Tajima, Chang-Kweng Lim, Akitoyo Hotta und 6 weitere

Journal of General Virology · 2026

DOI: 10.1099/jgv.0.002267 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of General Virology, 2026. Verfasst von Takayuki Hishiki und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Development, National Institute of Infectious Diseases, Japan Institute for Health Security, Shinjuku, Tokyo, Japan. Hauptthemen laut MEDLINE: Receptor, Interferon alpha-beta, Receptors, Interferon, Dengue, Antibody-Dependent Enhancement. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigated the pathogenicity of various dengue virus (DENV) strains using a newly established double-knockout (DKO) mouse model lacking both type I and type II IFN receptors ( Ifnar1–Ifngr1 DKO), rendering the mice highly susceptible to DENV infection. Survival, body weight changes and histopathological outcomes were assessed to characterize strain-specific pathogenicity and the potential for antibody-dependent enhancement (ADE). We observed significant strain-dependent variation in virulence. Notably, certain strains, such as DENV-1 02-20, exhibited pronounced ADE, evidenced by increased mortality and weight loss following pre-administration of the anti-DENV monoclonal antibody 4G2. These effects were more severe than those observed in single-knockout mice ( Ifnar1 KO or Ifngr1 KO) and in control groups. Histopathological examination revealed necrotic lesions in the brain and spinal cord, particularly in the olfactory bulb and cerebral cortex, along with extensive apoptosis of splenic lymphocytes, indicating severe immune activation and tissue damage. Our findings demonstrate that this lethal dengue infection model using Ifnar1–Ifngr1 DKO mice is an effective and valuable platform for studying the complex dynamics of DENV pathogenesis, immune responses and antibody interactions, as well as for evaluating vaccines and therapeutic strategies aimed at improving future prevention and treatment strategies for DENV infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Interferon alpha-betaReceptors, InterferonDengueAntibody-Dependent EnhancementDengue VirusAnimalsMice, KnockoutMiceDisease Models, AnimalInterferon gamma ReceptorAntibodies, ViralBrainVirulenceSpinal CordMice, Inbred C57BLSurvival Analysis

Stichwörter der Autor:innen

Ifnar1–Ifngr1 double-knockout (DKO) miceantibody-dependent enhancement (ADE)dengue virus (DENV)mouse model

Substanzen

Receptor, Interferon alpha-betaReceptors, InterferonIfnar1 protein, mouseInterferon gamma ReceptorAntibodies, Viral

Autor:innen und Institutionen

  • Department of Drug Development, National Institute of Infectious Diseases, Japan Institute for Health Security, Shinjuku, Tokyo, Japan.
  • Department of Veterinary Science, National Institute of Infectious Diseases, Japan Institute for Health Security, Shinjuku, Tokyo, Japan.
  • Department of Infectious Disease Pathology, National Institute of Infectious Diseases, Japan Institute for Health Security, Shinjuku, Tokyo, Japan.
  • Department of Virology I, National Institute of Infectious Diseases, Japan Institute for Health Security, Shinjuku, Tokyo, Japan.
  • Laboratory of Bacteria Collection Bank, Research Center for Biosafety, Laboratory Animal and Pathogen Bank, National Institute of Infectious Diseases, Japan Institute for Health Security, Shinjuku, Tokyo, Japan.
  • Research Center for Vaccine Development, National Institute of Infectious Diseases, Japan Institute for Health Security, Shinjuku, Tokyo, Japan.

Förderung

  • JSPS KAKENHI
  • Japan Agency for Medical Research and Development

Zitieren

APA

Hishiki, T., Virhuez-Mendoza, M., Sakai, Y., Uda, A., Ozono, S., Sato, Y., Machiya, S., Sato, K., Utsui, Y., Tajima, S., Lim, C. K., Hotta, A., Kuroda, Y., Yamamoto, T., Takahashi, Y., Suzuki, T., Watashi, K., & Maeda, K. (2026). Strain-specific pathogenicity and antibody-dependent enhancement of dengue virus infection in Ifnar1–Ifngr1 double-knockout mice. Journal of General Virology. https://doi.org/10.1099/jgv.0.002267

Vancouver

Hishiki T, Virhuez-Mendoza M, Sakai Y, Uda A, Ozono S, Sato Y, et al. Strain-specific pathogenicity and antibody-dependent enhancement of dengue virus infection in Ifnar1–Ifngr1 double-knockout mice. Journal of General Virology. 2026. doi:10.1099/jgv.0.002267

BibTeX
@article{Hishiki2026,
  author = {Hishiki, Takayuki and Virhuez-Mendoza, Milagros and Sakai, Yusuke and Uda, Akihiko and Ozono, Seiya and Sato, Yuko and Machiya, Sorane and Sato, Kotomi and Utsui, Yuta and Tajima, Shigeru and Lim, Chang-Kweng and Hotta, Akitoyo and Kuroda, Yudai and Yamamoto, Tsukasa and Takahashi, Yoshimasa and Suzuki, Tadaki and Watashi, Koichi and Maeda, Ken},
  title = {Strain-specific pathogenicity and antibody-dependent enhancement of dengue virus infection in Ifnar1–Ifngr1 double-knockout mice},
  journal = {Journal of General Virology},
  year = {2026},
  doi = {10.1099/jgv.0.002267}
}
Kostenlos starten →